Draft Agenda- Subject to Change | ||||
09:00 | Inauguration | |||
09:05 |
| |||
09:15 | Speaker Introduction & Memento Presentation | |||
09:45 |
| |||
10:25 | Q/A Discussion | |||
10:30 | Group Photograph | |||
10:40 | Coffee Break and Networking Session | |||
Session 1:MedChem Approaches for Phytochemicals | ||||
11:10 |
| |||
11:40 | Design and Development of Modern Efficacious Formulations of Aloe vera and Study of their Quality Aspects | |||
12:00 | Supercritical CO2 Extraction of Herbal Drugs | |||
12:20 |
| |||
12:50 | Q/A Discussion | |||
13:00 | Poster Evaluation Session | |||
13:15 | Lunch Break and Networking Session | |||
Session 2:Techniques for Development of Novel Biomolecules | ||||
14:00 | Designing Naturally Occurring Glycosaminoglycan Structures for a Wide Spectrum of Biomedical Applications | |||
14:20 |
| |||
14:50 | Q/A Discussion | |||
Session 3:Overcoming Problems of Drug Resistance | ||||
15:00 |
| |||
15:30 |
| |||
15:50 | TECHSPOT-Computational tools for designing and screening analogs for medicinal chemistry research | |||
16:05 | Q/A Discussion | |||
16:15 | Coffee Break and Networking Session | |||
16:45 |
| |||
17:15 | Natural Products: IMPs, PAINS, Pride, and Prejudices | |||
17:45 | Q/A Discussion | |||
17:50 | End of First Day of Conference |
Session 4:Current Strategies for Developing Bioactive Small Molecules-I | ||||
09:30 |
| |||
10:00 | Small Molecules as Tools for Biological Systems Manipulation | |||
10:20 | Q/A Discussion | |||
10:30 | TECHSPOT-Pharmaceutical HTS solutions | |||
10:45 | Coffee Break and Networking Session | |||
Session 5:Current Strategies for Developing Bioactive Small Molecules-II | ||||
11:15 | Expeditious Synthesis of Bacterial Glycoconjugates | |||
11:35 | Study of DNA Interaction with Co (III) Complexes bearing Hydroxamic Acid and 1, 10 phenanthroline as a Coligand | |||
11:55 | Boronic acid based Small Molecules as Potential Anticancer Agents | |||
12:15 | Q/A Discussion | |||
Session 6:Receptor Inhibition - Successful Strategy for Alteration of Biological Response-I | ||||
12:25 | Histone Acetyltransferase Inhibitors, From Screening to Optimization - A Tricky Track | |||
12:45 | EGFR Structure-based Bioactive Pharmacophore Model for Identifying Next-Generation Kinase Inhibitors against Clinically Relevant Mutations | |||
13:05 | Q/A Discussion | |||
13:10 | Poster Evaluation Session | |||
13:30 | Lunch Break and Networking Session | |||
Session 7:Receptor Inhibition - Successful Strategy for Alteration of Biological-II | ||||
14:30 | Freezing Essential Enzyme Motion for Catalysis: An Efficient Approach for Shikimate Kinase Inhibition | |||
14:50 | Design, Synthesis and Optimization of bis-amide Derivatives as CSF1R Inhibitors | |||
15:10 | Q/A Discussion | |||
15:20 | Coffee Break and Networking Session | |||
Session 8: Computational Approaches for Natural Products | ||||
15:45 | Harvesting Nature’s Diversity of Glycosaminoglycans for Therapy | |||
16:05 | Chemoinformatics Approach for Drug Discovery of Novel Molecules inspired by Metabolomics of Indian Medicinal and Aromatic Plants | |||
16:25 | Q/A Discussion | |||
Session 9: Academic Drug Discovery(Oral Presentation Session) | ||||
16:35 | Biological Activity Evaluation of Methanolic Extract of Solanum nigrum Leaves and Virtual Screening, Molecular Docking, PASS Analysis and Bioactivity Score Prediction of Selected Phytoconstituents | |||
16:45 | The Anti-Metastatic Effect of Mongolian Chelidonium majus L. Ethanol Extract in SK-HEP1 Hepatocellular Carcinoma | |||
16:55 | Anti-inflammatory Activity of Ethanolic Extracts from Tinospora crispa in LPS activated RAW 264.7 Macrophages | |||
17:05 | Mechanism behind the action of Triterpenoid Glycoside in Experimental Autoimmune Encephalomyelitis | |||
17:15 | Atom-Based 3D-QSAR, Molecular Docking and Dynamics Studies for Designing Potent Inhibitors against Human MAO-B | |||
17:35 | Poster Award Presentation | |||
17:40 | Closing Remarks | |||
17:45 | End of Conference |